Cargando…
MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
BACKGROUND: Pancreatic cancer is one of the most aggressive cancers, and the aggressiveness of pancreatic cancer is in part due to its intrinsic and extrinsic drug resistance characteristics, which are also associated with the acquisition of epithelial-to-mesenchymal transition (EMT). Increasing evi...
Autores principales: | Lu, Yuhua, Lu, Jingjing, Li, Xiaohong, Zhu, Hui, Fan, Xiangjun, Zhu, Shajun, Wang, Yao, Guo, Qingsong, Wang, Lei, Huang, Yan, Zhu, Mingyan, Wang, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923443/ https://www.ncbi.nlm.nih.gov/pubmed/24521357 http://dx.doi.org/10.1186/1471-2407-14-85 |
Ejemplares similares
-
3D Culture of MIN-6 Cells on Decellularized Pancreatic Scaffold: In Vitro and In Vivo Study
por: Wu, Di, et al.
Publicado: (2015) -
Transcriptome Analysis of Induced Pluripotent Stem Cell (iPSC)-derived Pancreatic β-like Cell Differentiation
por: Huang, Yan, et al.
Publicado: (2017) -
MiR-573 suppresses cell proliferation, migration and invasion via regulation of E2F3 in pancreatic cancer
por: Pengcheng, Zhou, et al.
Publicado: (2021) -
MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells
por: Xiong, Yicheng, et al.
Publicado: (2018) -
Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition
por: Haraguchi, Takeshi, et al.
Publicado: (2016)